AlphaYou
Overview
Smart-money signal on NTRA this 14d.
Key stats
Sep 5- Open
- $323.92
- 52-wk high
- $343.18
- High
- $329.05
- 52-wk low
- $157.43
- Low
- $323.42
- Prev close
- $327.67
- Mkt cap
- $47.23B
- Volume
- 968.2K
- Fwd P/E
- 5000.0x
- Beta
- 1.53
- P/S
- 17.4x
- P/B
- 25.4x
- Profit margin
- -7.1%
- Op margin
- -10.3%
- ROE
- -12.5%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
-$0.47 expected
Revenue
$661.3M expected
The release did not provide a source-backed EPS figure.
2026 guidance
$2.85B to $2.91B
No comparable estimate
What the street expects next
EPS expected
-$0.61 to $0.13
Revenue expected
19 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $592.2M | $665.5M | $696.6M | $752.8M |
| Cost of what it sold | $207.8M | $218.7M | $245.2M | $267.6M |
| Gross profit | $384.4M | $446.8M | $451.4M | $485.2M |
| What it spent | ||||
| Research and development | $173.4M | $175.2M | $210.7M | $228.1M |
| Sales and admin | $308.5M | $291.3M | $327.9M | $327.2M |
| Other operating costs | — | — | $6.3M | $5.7M |
| Total operating expenses | $482.0M | $469.6M | $545.0M | $561.0M |
| What was left | ||||
| Operating profit | -$97.6M | -$22.8M | -$93.5M | -$75.8M |
| Interest on debt | $1.0M | $7.1M | $892.0K | $890.0K |
| Profit before tax | -$87.3M | -$13.3M | -$84.8M | -$67.2M |
| Tax | $207.0K | -$60.6M | $283.0K | -$261.0K |
| Net profit | -$87.5M | $47.3M | -$85.1M | -$67.0M |
| EBITDA | -$76.4M | $7.9M | -$65.5M | -$45.2M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Natera president Solomon Moshkevich sells over $5.9m in shares
NeutralSep 4Natera settles class action over prenatal tests for $8.25M
Leans bearishSep 4Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
BullishAug 28Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
BullishAug 27Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST
NeutralAug 25Natera Inc (NTRA) News, Articles, Events & Latest Updates
BullishAug 25Natera (NTRA) As Druckenmiller Backs Growth Story, Is The Valuation Already Priced In?
NeutralAug 24NTRA|Natera Inc|Price:332.030|Chg%:+7.190
BullishAug 22
Macro
10 macro signals shaping NTRA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results